| Spirig HealthCare AG - Bortezomib liquid Spirig HC 3.5 mg/1.4 ml, Injektionslösung |
| 67421 | | 01 | | Bortezomib liquid Spirig HC 3.5 mg/1.4 ml | | Injektionslösung | | L01XG01 | | Bortezomib | | 09.12.2019 | | |
|
| Composition |
| bortezomibum 3.5 mg, mannitolum, natrii chloridum corresp. natrium 4.96 mg, aqua ad iniectabile, q.s. ad solutionem pro 1.4 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Bortezomib | 3.5mg / 1.4ml |
| | BAG: Active Agent | Dose |
|---|
| Bortezomib | 3.5 mg |
| | | | Inactive agents |
|---|
| Mannitol | | Sodium Chloride |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 372.78 | 421.85 | A | SL | No |
|
